Toichi Takenaka

2.2k total citations
106 papers, 1.8k citations indexed

About

Toichi Takenaka is a scholar working on Molecular Biology, Cardiology and Cardiovascular Medicine and Physiology. According to data from OpenAlex, Toichi Takenaka has authored 106 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 43 papers in Molecular Biology, 21 papers in Cardiology and Cardiovascular Medicine and 17 papers in Physiology. Recurrent topics in Toichi Takenaka's work include Receptor Mechanisms and Signaling (28 papers), Nitric Oxide and Endothelin Effects (13 papers) and Eicosanoids and Hypertension Pharmacology (12 papers). Toichi Takenaka is often cited by papers focused on Receptor Mechanisms and Signaling (28 papers), Nitric Oxide and Endothelin Effects (13 papers) and Eicosanoids and Hypertension Pharmacology (12 papers). Toichi Takenaka collaborates with scholars based in Japan, United Kingdom and Norway. Toichi Takenaka's co-authors include Hiroo Maeno, Michio Terai, Kazuo Honda, Osamu Inagaki, J Handa, Wataru Uchida, Masaharu Asano, Tomihisa Kawasaki, Masuo Murakami and Kumiko Shiono and has published in prestigious journals such as Biochemical Journal, Journal of Medicinal Chemistry and The Journal of Urology.

In The Last Decade

Toichi Takenaka

101 papers receiving 1.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Toichi Takenaka Japan 25 781 356 246 237 234 106 1.8k
Noel J. Cusack United Kingdom 29 833 1.1× 350 1.0× 452 1.8× 238 1.0× 234 1.0× 61 2.2k
Erwin Bischoff Germany 24 826 1.1× 159 0.4× 224 0.9× 221 0.9× 68 0.3× 49 2.0k
Sen T. Kau United States 15 627 0.8× 97 0.3× 184 0.7× 68 0.3× 112 0.5× 46 1.4k
Wolfram Steinke Germany 15 591 0.8× 487 1.4× 582 2.4× 134 0.6× 64 0.3× 31 1.7k
Zen‐ichi Terashita Japan 25 581 0.7× 506 1.4× 594 2.4× 252 1.1× 150 0.6× 72 2.1k
Osamu Inagaki Japan 16 326 0.4× 179 0.5× 70 0.3× 83 0.4× 90 0.4× 74 834
Cynthia L. Sundell United States 12 658 0.8× 507 1.4× 608 2.5× 62 0.3× 100 0.4× 16 1.8k
William H. Baricos United States 24 897 1.1× 605 1.7× 1.4k 5.9× 65 0.3× 184 0.8× 44 3.1k
Kazuo Minakuchi Japan 22 401 0.5× 133 0.4× 247 1.0× 54 0.2× 144 0.6× 106 1.6k
James W. Aiken United States 19 350 0.4× 423 1.2× 254 1.0× 76 0.3× 187 0.8× 26 1.4k

Countries citing papers authored by Toichi Takenaka

Since Specialization
Citations

This map shows the geographic impact of Toichi Takenaka's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Toichi Takenaka with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Toichi Takenaka more than expected).

Fields of papers citing papers by Toichi Takenaka

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Toichi Takenaka. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Toichi Takenaka. The network helps show where Toichi Takenaka may publish in the future.

Co-authorship network of co-authors of Toichi Takenaka

This figure shows the co-authorship network connecting the top 25 collaborators of Toichi Takenaka. A scholar is included among the top collaborators of Toichi Takenaka based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Toichi Takenaka. Toichi Takenaka is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Tsukamoto, Katsura & Toichi Takenaka. (2016). Role of Academia in Regulatory Science for Global Drug Development. YAKUGAKU ZASSHI. 136(4). 543–547. 1 indexed citations
2.
Yatsu, Takeyuki, Yukinori Arai, Kenji Takizawa, et al.. (1998). Effect of YM435, a Dopamine DA1 Receptor Agonist, in a Canine Model of Ischemic Acute Renal Failure. General Pharmacology The Vascular System. 31(5). 803–807. 9 indexed citations
3.
Ohkura, Takashi, Shizuo Yamada, Yoshiharu Deguchi, et al.. (1998). Ex vivo occupancy by tamsulosin of α1-adrenoceptors in rat tissues in relation to the plasma concentration. Life Sciences. 63(24). 2147–2155. 26 indexed citations
4.
Takizawa, Kenji, et al.. (1997). Hypotensive Effects of YM430, a 1,4-Dihydropyridine Derivative, in Spontaneously Hypertensive Rats and Renal Hypertensive Dogs.. The Japanese Journal of Pharmacology. 73(2). 113–124. 1 indexed citations
5.
Yatsu, Takeyuki, Yuichi Tomura, Atsuo Tahara, et al.. (1997). Pharmacological profile of YM087, a novel nonpeptide dual vasopressin V1A and V2 receptor antagonist, in dogs. European Journal of Pharmacology. 321(2). 225–230. 59 indexed citations
6.
Arai, Yukinori, et al.. (1997). Antianginal Effects of YM430, a Novel Calcium Entry–Blocking and β-Adrenoceptor–Blocking Agent in Several Experimental Angina Models. General Pharmacology The Vascular System. 29(4). 545–550. 5 indexed citations
7.
Kashiwa, Makoto, et al.. (1997). Pharmacological Properties of YM17E, an Acyl-CoA:Cholesterol Acyltransferase Inhibitor, and Diarrheal Effect in Beagle Dogs.. The Japanese Journal of Pharmacology. 73(1). 41–50. 14 indexed citations
8.
Uchida, Wataru, et al.. (1994). Cardiovascular effects of YM099, a novel K+ channel opener, in anesthetized and conscious dogs. European Journal of Pharmacology. 264(3). 285–293. 4 indexed citations
9.
Yamada, Shizuo, Mayumi Suzuki, Chiaki Tanaka, et al.. (1994). COMPARATIVE STUDY ON α1‐ADRENOCEPTOR ANTAGONIST BINDING IN HUMAN PROSTATE AND AORTA. Clinical and Experimental Pharmacology and Physiology. 21(5). 405–411. 58 indexed citations
10.
Uchida, Wataru, et al.. (1993). Cardiovascular effects of YM-16151-1 and its optical isomers: a novel calcium entry blocking and beta 1-adrenoceptor blocking agent.. PubMed. 321. 30–40. 2 indexed citations
11.
Shibasaki, Masayuki, Akira Fujimori, Osamu Inagaki, et al.. (1993). Antihypertensive effects of YM358, a novel angiotensin II receptor antagonist.. The Japanese Journal of Pharmacology. 61. 212–212. 1 indexed citations
12.
Takanashi, Masahiro, et al.. (1992). Characterization of a newly synthesized radioligand [3H)-YM617 and its selectivity for α1-adrenoceptor subtypes in rabbit tissues. The Japanese Journal of Pharmacology. 58. 387–387. 4 indexed citations
13.
Takenaka, Toichi, et al.. (1983). [Hodgkin's disease staging classification and procedures, with special reference to Ann Arbor classification].. PubMed. 41(11). 2469–74. 1 indexed citations
14.
Tomioka, Kazumi, Toshiyuki Yamada, & Toichi Takenaka. (1982). Comparison of airway obstruction induced by propranolol and YM-09538 (a combined alpha- and beta-adrenoceptor blocking drug).. PubMed. 256(1). 97–107. 4 indexed citations
15.
Takenaka, Toichi, et al.. (1982). Antihypertensive and Adrenoceptor Blocking Properties of new Sulfonamide-Substituted Phenylethylamines. Clinical and Experimental Hypertension Part A Theory and Practice. 4(1-2). 125–137. 26 indexed citations
16.
Fujikura, Takashi, et al.. (1982). Studies on benzenesulfonamide derivatives with .ALPHA.- and .BETA.-adrenergic antagonistic and antihypertensive activities.. Chemical and Pharmaceutical Bulletin. 30(11). 4092–4101. 14 indexed citations
17.
Terai, Michio, Toichi Takenaka, & Hiroo Maeno. (1981). Inhibition of calcium influx in rabbit aorta by nicardipine hydrochloride (YC-93). Biochemical Pharmacology. 30(4). 375–378. 69 indexed citations
18.
Takenaka, Toichi & J Handa. (1979). Cerebrovascular effects of YC-93, a new vasodilator, in dogs, monkeys and human patients.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 17(1). 1–11. 71 indexed citations
19.
Iwanami, Masaru, Tadao Shibanuma, M. Y. Fujimoto, et al.. (1979). Synthesis of new water-soluble dihydropyridine vasodilators.. Chemical and Pharmaceutical Bulletin. 27(6). 1426–1440. 110 indexed citations
20.
Takenaka, Fumio, et al.. (1972). Effects of 1-(7-indenyloxy)-3-isopropylaminopropan-2-ol hydrochloride (YB-2) on coronary circulation and myocardial metabolism. Folia Pharmacologica Japonica. 68(6). 848–856. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Noel J. Cusack Breakdown of academic impact, for papers by Erwin Bischoff Breakdown of academic impact, for papers by Sen T. Kau Breakdown of academic impact, for papers by Wolfram Steinke Breakdown of academic impact, for papers by Zen‐ichi Terashita Breakdown of academic impact, for papers by Osamu Inagaki Breakdown of academic impact, for papers by Cynthia L. Sundell Breakdown of academic impact, for papers by William H. Baricos Breakdown of academic impact, for papers by Kazuo Minakuchi Breakdown of academic impact, for papers by James W. Aiken
Rankless by CCL
2026